Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Toripalimab
Pharma
Junshi, Coherus move Loqtorzi closer to another approval
Junshi revealed that a phase 3 trial of Loqtorzi plus Avastin prolonged the survival of first-line patients with hepatocellular carcinoma.
Kevin Dunleavy
Jun 12, 2024 11:45am
Coherus lays off 30% of employees amid new 'sharpened focus'
Mar 13, 2024 6:10pm
Coherus prices China-made PD-1 at 20% discount to Keytruda
Nov 27, 2023 6:10pm
Coherus hits pair of FDA hurdles
Sep 25, 2023 11:42am
Leqembi, Enhertu, Samsung Biologics—Fierce Pharma Asia
Jun 9, 2023 9:35am
